CHCHD3 and metabolic dysfunction-associated steatotic liver disease: Specifically, hepatocyte CHCHD2 contributed to liver fibrosis in nonalcoholic fatty liver disease (NAFLD) [14], whereas CHCHD3 was found to improve mitochondrial function via increasing mitochondrial ROS and promoting ferroptosis, by which modulated tumorigenesis [15].